AU2003282722A8 - Therapeutic compositions - Google Patents

Therapeutic compositions

Info

Publication number: AU2003282722A8
Authority: AU; Australia
Prior art keywords: therapeutic compositions; therapeutic; compositions
Prior art date: 2002-10-02
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003282722A

Other versions

AU2003282722A1 (en

Inventor

David Bumcrot

Nagesh Mahanthappa

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Alnylam Pharmaceuticals Inc

Original Assignee

Alnylam Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-10-02

Filing date

2003-10-02

Publication date

2004-04-23

2003-10-02 Application filed by Alnylam Pharmaceuticals Inc filed Critical Alnylam Pharmaceuticals Inc

2004-04-23 Publication of AU2003282722A1 publication Critical patent/AU2003282722A1/en

2004-04-23 Publication of AU2003282722A8 publication Critical patent/AU2003282722A8/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Genetics & Genomics (AREA)
Biomedical Technology (AREA)
Chemical & Material Sciences (AREA)
Molecular Biology (AREA)
Organic Chemistry (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Zoology (AREA)
Bioinformatics & Cheminformatics (AREA)
Wood Science & Technology (AREA)
Microbiology (AREA)
Plant Pathology (AREA)
Physics & Mathematics (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
Biophysics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

AU2003282722A 2002-10-02 2003-10-02 Therapeutic compositions Abandoned AU2003282722A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US41569802P	2002-10-02	2002-10-02
US60/415,698		2002-10-02
PCT/US2003/031717 WO2004030634A2 (en)	2002-10-02	2003-10-02	Therapeutic compositions

Publications (2)

Publication Number	Publication Date
AU2003282722A1 AU2003282722A1 (en)	2004-04-23
AU2003282722A8 true AU2003282722A8 (en)	2004-04-23

Family

ID=32069900

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003282722A Abandoned AU2003282722A1 (en)	2002-10-02	2003-10-02	Therapeutic compositions

Country Status (2)

Country	Link
AU (1)	AU2003282722A1 (en)
WO (1)	WO2004030634A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE102005003788A1 (en)	2005-01-19	2006-07-20	Eberhard-Karls-Universität Tübingen Universitätsklinikum	siRNA molecules for the treatment of blood vessels
US8188060B2 (en)	2008-02-11	2012-05-29	Dharmacon, Inc.	Duplex oligonucleotides with enhanced functionality in gene regulation
KR101141544B1 (en)	2009-03-13	2012-05-03	한국과학기술원	Multi-conjugate of siRNA and preparing method thereof
WO2010141511A2 (en)	2009-06-01	2010-12-09	Halo-Bio Rnai Therapeutics, Inc.	Polynucleotides for multivalent rna interference, compositions and methods of use thereof
IL316159A (en)	2015-06-15	2024-12-01	Mpeg La Llc	Oligonucleotides with a defined number of polymers and methods of their preparation
WO2017035278A1 (en)	2015-08-24	2017-03-02	Halo-Bio Rnai Therapeutics, Inc.	Polynucleotide nanoparticles for the modulation of gene expression and uses thereof
WO2018145086A1 (en)	2017-02-06	2018-08-09	Mpeg La, Llc	Multimeric oligonucleotides having decreased kidney clearance
EP4416292A2 (en)	2021-10-14	2024-08-21	Arsenal Biosciences, Inc.	Immune cells having co-expressed shrnas and logic gate systems
AU2023343318A1 (en)	2022-09-13	2025-04-10	Arsenal Biosciences, Inc.	Immune cells having co-expressed tgfbr shrnas
AU2023342285A1 (en)	2022-09-16	2025-03-27	Arsenal Biosciences, Inc.	Immune cells with combination gene perturbations
US12257304B2 (en)	2023-03-03	2025-03-25	Arsenal Biosciences, Inc.	Systems targeting PSMA and CA9
WO2025199338A1 (en)	2024-03-20	2025-09-25	Arsenal Biosciences, Inc.	Systems targeting slc34a2 and tmprss4 and methods of use thereof

2003
- 2003-10-02 WO PCT/US2003/031717 patent/WO2004030634A2/en not_active Ceased
- 2003-10-02 AU AU2003282722A patent/AU2003282722A1/en not_active Abandoned

Also Published As

Publication number	Publication date
AU2003282722A1 (en)	2004-04-23
WO2004030634A3 (en)	2004-09-23
WO2004030634A2 (en)	2004-04-15

Publication	Publication Date	Title
GB2389530B (en)	2007-01-10	Pharmaceutical compositions
EP1603543A4 (en)	2009-03-04	Therapeutic compositions
GB0212062D0 (en)	2002-07-03	Jetable compositions
IL165372A0 (en)	2006-01-15	Immunodenic compositions
GB0224415D0 (en)	2002-11-27	Compositions
GB2391473B (en)	2004-07-07	Pharmaceutical compositions
EP1556023A4 (en)	2010-06-02	Nutritional or therapeutic compositions
AU2003279911A8 (en)	2004-05-04	Therapeutic formulations
GB0208609D0 (en)	2002-05-22	Compositions
GB0222945D0 (en)	2002-11-13	Therapeutic compositions
GB2392618B (en)	2007-02-21	Compositions for therapeutic use
GB0229258D0 (en)	2003-01-22	Medicinal compositions
AU2003282722A8 (en)	2004-04-23	Therapeutic compositions
AU2002365093A8 (en)	2003-07-09	Therapeutic compositions
GB0221894D0 (en)	2002-10-30	Compositions
AU2003269904A8 (en)	2004-01-23	Antigen-polymer compositions
GB0203395D0 (en)	2002-03-27	Compositions
AU2003215150A8 (en)	2003-09-02	Therapeutic compounds
GB0213481D0 (en)	2002-07-24	Pharmaceutical compositions
GB0203396D0 (en)	2002-03-27	Compositions
GB0109428D0 (en)	2001-06-06	Therapeutic compositions
GB0317524D0 (en)	2003-08-27	Compositions
GB0208392D0 (en)	2002-05-22	Therapeutic compounds
GB2394114B (en)	2005-09-07	Compositions
AU2003216382A8 (en)	2003-09-09	Idothyronine compositions

Legal Events

Date	Code	Title	Description
2005-07-21	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase